Robot maker · early
Robeauté
Developing self-propelled neurosurgical microrobots ~1.8 mm long (grain-of-rice scale) that navigate through brain tissue along curved trajectories to take biopsies, deliver drugs and place sensors, aiming to reach targets conventional straight-line neurosurgery cannot. Moving from animal studies toward first human clinical trials expected in 2026, with strategic input from Brainlab.
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
Robeauté neurosurgical microrobot
- Self-propelled 1.8 mm microrobot that navigates the brain's complex structures along curved paths for targeted treatment delivery; human trials expected 2026
vendor-stated pre-clinical microrobot capability
Claim source
Funding history
Publicly announced rounds
Venture
Plural, Cherry Ventures, Kindred Ventures, LocalGlobe, Think.Health, APEX Ventures
Round sourceHiring signal
Public job board · 2026-07-13
Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.
Company timeline
Milestones and announcements
Source ledger
1 unique public sources